TY - CHAP
T1 - Nerve growth factor-induced angiogenesis
T2 - 1. Endothelial cell tube formation assay
AU - Lazarovici, Philip
AU - Lahiani, Adi
AU - Gincberg, Galit
AU - Haham, Dikla
AU - Fluksman, Arnon
AU - Benny, Ofra
AU - Marcinkiewicz, Cezary
AU - Lelkes, Peter I.
N1 - Publisher Copyright:
© Springer Science+Business Media, LLC 2018.
PY - 2018
Y1 - 2018
N2 - Nerve growth factor (NGF) is a neurotrophin promoting survival, proliferation, differentiation, and neuroprotection in the embryonal and adult nervous system. NGF also induces angiogenic effects in the cardiovascular system, which may be beneficial in engineering new blood vessels and for developing novel anti-angiogenesis therapies for cancer. Angiogenesis is a cellular process characterized by a number of events, including endothelial cell migration, invasion, and assembly into capillaries. In vitro endothelial tube formation assays are performed using primary human umbilical vein endothelial cells, human aortic endothelial cells, and other human or rodent primary endothelial cells isolated from the vasculature of both tumors and normal tissues. Immortalized endothelial cell lines are also used for these assays. When seeded onto Matrigel, these cells reorganize to create tubelike structure, which may be used as models for studying some aspects of in vitro angiogenesis. Image acquisition by light and fluorescence microscopy and/or quantification of fluorescently labeled cells can be carried out manually or digitally, using commercial software and automated image processing. Here we detail materials, procedure, assay conditions, and cell labeling for quantification of endothelial cell tube formation. This model can be applied to study cellular and molecular mechanisms by which NGF or other neurotrophins promote angiogenesis. This model may also be useful for the development of potential angiogenic and/or anti-angiogenic drugs targeting NGF receptors.
AB - Nerve growth factor (NGF) is a neurotrophin promoting survival, proliferation, differentiation, and neuroprotection in the embryonal and adult nervous system. NGF also induces angiogenic effects in the cardiovascular system, which may be beneficial in engineering new blood vessels and for developing novel anti-angiogenesis therapies for cancer. Angiogenesis is a cellular process characterized by a number of events, including endothelial cell migration, invasion, and assembly into capillaries. In vitro endothelial tube formation assays are performed using primary human umbilical vein endothelial cells, human aortic endothelial cells, and other human or rodent primary endothelial cells isolated from the vasculature of both tumors and normal tissues. Immortalized endothelial cell lines are also used for these assays. When seeded onto Matrigel, these cells reorganize to create tubelike structure, which may be used as models for studying some aspects of in vitro angiogenesis. Image acquisition by light and fluorescence microscopy and/or quantification of fluorescently labeled cells can be carried out manually or digitally, using commercial software and automated image processing. Here we detail materials, procedure, assay conditions, and cell labeling for quantification of endothelial cell tube formation. This model can be applied to study cellular and molecular mechanisms by which NGF or other neurotrophins promote angiogenesis. This model may also be useful for the development of potential angiogenic and/or anti-angiogenic drugs targeting NGF receptors.
KW - Animals
KW - Cell Proliferation/drug effects
KW - Cells, Cultured
KW - Endothelial Cells/cytology
KW - Human Umbilical Vein Endothelial Cells
KW - Humans
KW - Image Processing, Computer-Assisted
KW - Microscopy, Fluorescence
KW - Molecular Imaging
KW - Neovascularization, Pathologic/diagnostic imaging
KW - Neovascularization, Physiologic/drug effects
KW - Nerve Growth Factor/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85037689136&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000433438800019&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1007/978-1-4939-7571-6_18
DO - 10.1007/978-1-4939-7571-6_18
M3 - Chapter
C2 - 29222786
VL - 1727
T3 - Methods in molecular biology (Clifton, N.J.)
SP - 239
EP - 250
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -